학술논문
P619: TRACKING DISEASE PARAMETERS BY MRD, CT AND PET IN FIRST LINE CLL PATIENTS TREATED WITH FIXED DURATION IBRUTINIB‐VENETOCLAX; INTERIM ANALYSIS OF THE FIRST 30 PATIENTS IN HOVON 158/NEXT STEP TRIAL.
Document Type
Article
Author
Kersting, Sabina; Levin, Mark‐David; Dubois, Julie; van Norden, Yvette; Dobber, Johan; Jauw, Yvonne; van der Kevie‐Kersemaekers, Anne‐Marie; Mellink, Clemens; Da Cunha‐Bang, Caspar; Van Desr Burg, Leonie; Te Raa, Doreen; de Boer, Fransien; Droogendijk, Jolanda; Idink, Cecile; De Heer, Koen; Nijziel, Marten; Tick, Lidwine; Ludwig, Inge; Silbermann, Mathijs; Beeker, Aart
Source
HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
Subject
Language
ISSN
25729241